• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Continuous renal replacement therapy and the COVID pandemic.连续性肾脏替代治疗与新冠疫情。
Semin Dial. 2021 Nov;34(6):561-566. doi: 10.1111/sdi.12962. Epub 2021 Mar 11.
2
Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care.儿童 2019 冠状病毒病急性肾损伤及肾脏替代治疗的特殊考虑:来自欧洲儿童和新生儿重症监护学会重症肾脏病学组的观点。
Blood Purif. 2021;50(2):150-160. doi: 10.1159/000509677. Epub 2020 Jul 14.
3
Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States.估算美国在 COVID-19 大流行期间连续肾脏替代疗法提供能力短缺。
Am J Kidney Dis. 2020 Nov;76(5):696-709.e1. doi: 10.1053/j.ajkd.2020.07.005. Epub 2020 Jul 28.
4
Ensuring Sustainability of Continuous Kidney Replacement Therapy in the Face of Extraordinary Demand: Lessons From the COVID-19 Pandemic.在面临巨大需求的情况下确保连续性肾脏替代治疗的可持续性:COVID-19 大流行带来的经验教训。
Am J Kidney Dis. 2020 Sep;76(3):392-400. doi: 10.1053/j.ajkd.2020.05.008. Epub 2020 Jun 4.
5
Meeting the Demand for Renal Replacement Therapy during the COVID-19 Pandemic: A Manufacturer's Perspective.从制造商角度看COVID-19大流行期间满足肾脏替代治疗需求的情况
Kidney360. 2020 Dec 29;2(2):350-354. doi: 10.34067/KID.0006192020. eCollection 2021 Feb 25.
6
Continuous Renal Replacement Therapy for a Patient with Severe COVID-19.连续性肾脏替代治疗用于重症 COVID-19 患者。
Blood Purif. 2021;50(1):129-131. doi: 10.1159/000508062. Epub 2020 Jun 11.
7
Deployment of a New CRRT/PIRRT Device during the COVID-19 Pandemic Emergency: Organizational Challenges and Implementation Results.COVID-19 大流行紧急情况下新型 CRRT/PIRRT 设备的部署:组织挑战和实施结果。
Blood Purif. 2021;50(3):390-398. doi: 10.1159/000511726. Epub 2020 Nov 10.
8
Provision of acute renal replacement therapy, using three separate modalities, in critically ill patients during the COVID-19 pandemic. An after action review from a UK tertiary critical care centre.在新冠疫情期间,一家英国三级重症监护中心采用三种不同方式为危重症患者提供急性肾替代治疗。事后总结评估。
J Crit Care. 2021 Apr;62:190-196. doi: 10.1016/j.jcrc.2020.12.023. Epub 2020 Dec 28.
9
Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil.急性肾损伤和危重症 COVID-19 患者的肾脏替代治疗:危险因素和结局:巴西单中心经验。
Blood Purif. 2021;50(4-5):520-530. doi: 10.1159/000513425. Epub 2020 Dec 18.
10
COVID-19 in ESRD and Acute Kidney Injury.COVID-19 与终末期肾病和急性肾损伤。
Blood Purif. 2021;50(4-5):610-620. doi: 10.1159/000513214. Epub 2020 Dec 15.

引用本文的文献

1
Dialysis resource allocation in critical care: the impact of the COVID-19 pandemic and the promise of big data analytics.重症监护中的透析资源分配:COVID-19大流行的影响及大数据分析的前景
Front Nephrol. 2023 Oct 26;3:1266967. doi: 10.3389/fneph.2023.1266967. eCollection 2023.
2
The patient safety in extracorporeal blood purification treatments of critical patients.危重症患者体外血液净化治疗中的患者安全。
Front Nephrol. 2022 Jul 22;2:871480. doi: 10.3389/fneph.2022.871480. eCollection 2022.
3
Rapid implementation of an emergency on-site CKRT dialysate production system during the COVID-19 pandemic.在 COVID-19 大流行期间,快速实施紧急现场 CKRT 透析液生产系统。
BMC Nephrol. 2023 Aug 22;24(1):245. doi: 10.1186/s12882-023-03260-9.
4
Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era.COVID-19大流行后时代CAR-T细胞疗法接受者管理的多学科建议。
Exp Hematol Oncol. 2023 Jul 27;12(1):66. doi: 10.1186/s40164-023-00426-x.
5
Good practice statements for antithrombotic therapy in the management of COVID-19: Guidance from the SSC of the ISTH.COVID-19 管理中的抗血栓治疗良好实践声明:ISTH 的 SSC 指南。
J Thromb Haemost. 2022 Oct;20(10):2226-2236. doi: 10.1111/jth.15809. Epub 2022 Jul 29.
6
Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies.COVID-19 导致肾损伤的机制和当前的药物治疗方法。
Inflamm Res. 2022 Jan;71(1):39-56. doi: 10.1007/s00011-021-01520-8. Epub 2021 Nov 21.

本文引用的文献

1
Urinary Sediment Microscopy in Acute Kidney Injury Associated with COVID-19.新型冠状病毒肺炎相关急性肾损伤中的尿沉渣显微镜检查
Kidney360. 2020 Jun 2;1(8):819-823. doi: 10.34067/KID.0003352020. eCollection 2020 Aug 27.
2
Acute Kidney Injury Associated with Coronavirus Disease 2019 in Urban New Orleans.急性肾损伤与城市新奥尔良的 2019 年冠状病毒病相关。
Kidney360. 2020 May 13;1(7):614-622. doi: 10.34067/KID.0002652020. eCollection 2020 Jul 30.
3
Dialysis Filter Life, Anticoagulation, and Inflammation in COVID-19 and Acute Kidney Injury.COVID-19与急性肾损伤中的透析滤器寿命、抗凝及炎症
Kidney360. 2020 Oct 20;1(12):1426-1431. doi: 10.34067/KID.0004322020. eCollection 2020 Dec 31.
4
Optimizing Kidney Replacement Therapy During the COVID-19 Pandemic Across a Complex Healthcare System.在复杂医疗系统中优化2019冠状病毒病大流行期间的肾脏替代治疗
Front Med (Lausanne). 2020 Dec 22;7:604182. doi: 10.3389/fmed.2020.604182. eCollection 2020.
5
High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy.COVID-19 相关急性肾损伤需要肾脏替代治疗的幸存者中,肾脏恢复率较高。
PLoS One. 2020 Dec 28;15(12):e0244131. doi: 10.1371/journal.pone.0244131. eCollection 2020.
6
COVID-19-Associated Glomerular Disease.COVID-19 相关肾小球疾病。
J Am Soc Nephrol. 2021 Jan;32(1):33-40. doi: 10.1681/ASN.2020060804. Epub 2020 Nov 19.
7
AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19.新冠肺炎危重症患者急性肾损伤行肾脏替代治疗。
J Am Soc Nephrol. 2021 Jan;32(1):161-176. doi: 10.1681/ASN.2020060897. Epub 2020 Oct 16.
8
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup.COVID-19 相关急性肾损伤:第 25 届急性疾病质量倡议(ADQI)工作组的共识报告。
Nat Rev Nephrol. 2020 Dec;16(12):747-764. doi: 10.1038/s41581-020-00356-5. Epub 2020 Oct 15.
9
Filter clotting with continuous renal replacement therapy in COVID-19.COVID-19中连续性肾脏替代疗法的滤器凝血
J Thromb Thrombolysis. 2021 May;51(4):966-970. doi: 10.1007/s11239-020-02301-6. Epub 2020 Oct 7.
10
Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy: A Single-Center Experience.接受连续性肾脏替代治疗的COVID-19患者的抗凝策略与滤器寿命:单中心经验
Clin J Am Soc Nephrol. 2020 Dec 31;16(1):124-126. doi: 10.2215/CJN.08430520. Epub 2020 Sep 17.

连续性肾脏替代治疗与新冠疫情。

Continuous renal replacement therapy and the COVID pandemic.

机构信息

Division of Nephrology, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Renal Epidemiology Group, Columbia University, New York, NY, USA.

出版信息

Semin Dial. 2021 Nov;34(6):561-566. doi: 10.1111/sdi.12962. Epub 2021 Mar 11.

DOI:10.1111/sdi.12962
PMID:33705575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8242500/
Abstract

Severe COVID-19 illness and the consequent cytokine storm and vasodilatory shock commonly lead to ischemic acute kidney injury (AKI). The need for renal replacement therapies (RRTs) in those with the most severe forms of AKI is considerable and risks overwhelming health-care systems at the peak of a surge. We detail the challenges and considerations involved in the preparation of a disaster response plan in situations such as the COVID-19 pandemic, which dramatically increase demand for nephrology services. Taking careful inventory of all aspects of an RRT program (personnel, consumables, and machines) before a surge in RRT arises and developing disaster contingency protocol anticoagulation and for shared RRT models when absolutely necessary are paramount to a successful response to such a disaster.

摘要

严重的 COVID-19 疾病以及随之而来的细胞因子风暴和血管舒张性休克通常会导致缺血性急性肾损伤(AKI)。在 AKI 最严重的情况下,需要进行肾脏替代治疗(RRT),而在疫情高峰期,这会给医疗系统带来巨大的压力。我们详细介绍了在 COVID-19 等大流行期间准备灾害应对计划所涉及的挑战和考虑因素,这种情况会极大地增加肾脏病服务的需求。在 RRT 需求激增之前,仔细盘点 RRT 计划的各个方面(人员、耗材和机器),并在绝对必要时制定灾难应急协议抗凝和共享 RRT 模型,对于成功应对此类灾害至关重要。